AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|
15.1 C
New York
Friday, October 30, 2026

Tag: statement

newsFORsourcecompanycontentinformationreleases1market

LG SIGNATURE PRESENTS THREE NEW PREMIUM APPLIANCE COLLECTIONS AT THE GUGGENHEIM MUSEUM IN NEW YORK

Leslie Bibb, John Mayer, Amaury Guichon and a Host of Cultural Tastemakers Came Together for an Evening Celebrating Personal Style, Design and the Newest...

T-MAXIMUM’s B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer

BEIJING, Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to...

Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China

TAIPEI, Oct. 12, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that it was notified by its licensing partner, Changchun GeneScience Pharmaceutical...

Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting

Key Highlights:Tegoprazan is the first and only P-CAB reported to demonstrate clinical improvement in both hallmark symptoms of NERD, heartburn and regurgitation, in a...

World’s doctors call for urgent solutions to harmful false health information

ROTTERDAM, Netherlands, Oct. 10, 2026 /CNW/ -- The World Medical Association (WMA), representing doctors worldwide, is prescribing necessary steps to curb false health information...

Evernorth Completes Business Combination with Armada Acquisition Corp. II

Company enters the public markets holding approximately 473 million XRP and approximately $300 million in gross cash proceeds; shares to begin trading on Nasdaq...

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare...

UCB Dedicates Site for New U.S. Biologics Manufacturing Campus in Georgia

Site dedication signals continued momentum for UCB's first U.S. manufacturing campusEmphasizes long-term commitment to advancing innovation, patient access, and workforce development in Gwinnett County and surrounding...

WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

JERSEY CITY, N.J., Oct. 9, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies,...

SEC Proposes Expanding Securities Eligible for Cross Trading by Registered Funds

Washington, D.C.--(Newsfile Corp. - October 9, 2026) - The Securities and Exchange Commission today proposed amendments to the...

CEO.CA’s Inside the Boardroom: Hayasa Metals on Major Partner Sole-Funding $10M+ Copper Exploration in Armenia

Toronto, Ontario--(Newsfile Corp. - October 9, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates...

Cyngn Autonomous Fleet Expands Operational Footprint Across Industrial Facilities in 2026

Fleet data reflects growing adoption of autonomous material movement across customer sites, with more than 11,600 missions completed year to date.MOUNTAIN VIEW, Calif., Oct....

CHINA KELI ELECTRIC ANNOUNCES APPLICATION FOR VOLUNTARY DELISTING FROM THE TSX VENTURE EXCHANGE IN ANTICIPATION OF DGEN TRANSACTION AND CSE LISTING

VANCOUVER, BC, Oct. 9, 2026 /CNW/ -- China Keli Electric Company Ltd. (the "Company") is pleased to announce that, in connection with its previously...

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

Phase 3 data presented at Fall Clinical Dermatology show high, sustained response rates in adults and adolescents, with nearly three-quarters achieving clear or almost...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStatement

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers